Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
29 Abril 2024 - 8:44AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Pursuant to §240. 14a-12
|
Korro Bio, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☐ |
Fee paid previously with preliminary materials. |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11 |
P.O. BOX 8016, CARY, NC 27512-9903 Scan QR for digital voting Meeting Materials: Notice of Meeting and Proxy Statement & Annual
Report or Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Stockholders Korro Bio, Inc. Meeting To Be Held On June 11, 2024 For Stockholders of record as of April 17, 2024 Annual Meeting of Stockholders To order paper
materials, use one of the Tuesday, June 11, 2024 1:30 PM, Eastern Time Annual Meeting will be held via live the internet - please visit www.proxydocs.com/KRRO for following methods. more details. You must register to attend the meeting online and/or
participate at www.proxydocs.com/KRRO. Internet: For a convenient way to view proxy materials, VOTE, and obtain www.investorelections.com/KRRO directions to attend the meeting go to www.proxydocs.com/KRRO To vote your proxy while visiting this site,
you will need the 12 digit control number in the box below. Call: 1-866-648-8133 This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this
notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Email: paper@investorelections.com Under United States Securities and Exchange Commission rules, proxy
materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the * If requesting material by e-mail, please send a blank e-mail with the internet. 12 digit control number (located below) in the
subject line. No other requests, instructions OR other inquiries should be included with your If you want to receive a paper or e-mail copy of the proxy material, you must request one. e-mail requesting material. There is no charge to you for
requesting a copy. In order to receive a paper package in time for this years meeting, you must make this request on or before May 31, 2024. Your control number Have the 12 digit control number located in the box above available when you
access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA Copyright © 2024 BetaNXT, Inc. or its affiliates. All Rights Reserved
Korro Bio, Inc. Annual Meeting of Stockholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR THE NOMINEES IN PROPOSAL 1 AND FOR
PROPOSALS 2 AND 3 PROPOSAL 1. Election of two Class II directors nominated by our board of directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders; 1.01 Ali Behbahani 1.02 Timothy Pearson 2. Approval of an
amendment to our Restated Certificate of Incorporation to limit the liability of certain officers as permitted by amendments to Delaware law; 3. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2024; 4. Transaction of any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.
Frequency Therapeutics (NASDAQ:FREQ)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Frequency Therapeutics (NASDAQ:FREQ)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024